(Q43916988)

28 November 2017

title

Atherogen lipid profile in HIV-1-infected patients with lipodystrophy syndrome (English)

1 reference

28 November 2017

3

Thiébaut R

1 reference

28 November 2017

8

Dabis F

1 reference

28 November 2017

Mercié P

1

1 reference

28 November 2017

Tchamgoué S

2

1 reference

28 November 2017

Viallard J

4

1 reference

28 November 2017

Faure I I

5

1 reference

28 November 2017

Dancourt V V

6

1 reference

28 November 2017

Marimoutou C

7

1 reference

28 November 2017

Rispal P

9

1 reference

28 November 2017

Darmon Y

10

1 reference

28 November 2017

Leng B

11

1 reference

28 November 2017

Pellegrin J

12

1 reference

28 November 2017

publication date

1 October 2000

1 reference

European Journal of Internal Medicine

28 November 2017

published in

1 reference

28 November 2017

volume

11

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

257-263

1 reference

Benign symmetric lipomatosis associated with protease inhibitors

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Abnormal fat distribution and use of protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Hypertrophy of the breasts in a patient treated with indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

"Buffalo hump" in men with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Visceral abdominal-fat accumulation associated with use of indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Protease inhibitor-associated hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Lipodystrophy in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Hypertriglyceridemia in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Severe premature coronary artery disease with protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

High-density lipoproteins in myocardial infarction survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

Chlamydia in coronary plaques--hidden culprit or harmless hobo?

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900103-5

7 January 2021

10.1016/S0953-6205(00)00103-5

Identifiers

DOI

1 reference

28 November 2017

1 reference